Advisors Preferred »

Halozyme Therapeutics shares owned by Advisors Preferred

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Advisors Preferred from 13F filings

Historical chart of Advisors Preferred investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Advisors Preferred consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Advisors Preferred

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0M 25k 41.32
2022-12-31 $364k 6.6k 55.13
2022-09-30 $317k 7.9k 39.98
2022-06-30 $355k 8.1k 44.05
2022-03-31 $455k 11k 41.60
2021-03-31 $2.9M 68k 42.43
2020-12-31 $1.7M 39k 42.41